Determination of ultrafiltrable and exchangeable copper in plasma: stability and reference values in healthy subjects

被引:80
作者
El Balkhi, Souleiman [1 ,3 ]
Poupon, Joel [1 ]
Trocello, Jean-Marc [2 ,3 ]
Leyendecker, Angelique [3 ]
Massicot, France [4 ]
Galliot-Guilley, Martine [1 ]
Woimant, France [2 ,3 ]
机构
[1] Hop Lariboisiere, Biol Toxicol Lab, AP HP, F-75475 Paris 10, France
[2] Hop Lariboisiere, Dept Neurol, AP HP, F-75475 Paris 10, France
[3] Hop Lariboisiere, Reference Ctr Wilson Dis, AP HP, F-75475 Paris 10, France
[4] Paris Descartes Univ, Toxicol Lab, Fac Pharm, F-75006 Paris, France
关键词
Free copper; Ultrafiltration; Wilson's disease; Labile-bound-copper; SERUM COPPER; WILSONS-DISEASE; D-PENICILLAMINE; BLOOD-PLASMA; CERULOPLASMIN; ULTRAFILTRATION; COMPONENTS; PROTEINS;
D O I
10.1007/s00216-009-2809-6
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The knowledge of copper (Cu) distribution in blood contributes to a better understanding of copper metabolism and to a better approach and follow up of related diseases such as Wilson's disease (WD). Many tests can be used to investigate patients who may have WD but they show many drawbacks and do not allow real patient monitoring. Knowing that the Cu overload can result from the free and easily exchangeable form of copper in plasma, a two-step method (ultrafiltration-determination by ETAAS) was carried out to determine these two fractions. The ultrafiltration procedure and the instrumental determination showed good repeatability, and a very low limit of detection was obtained (0.7 nmol/L). In vitro stability of both ultrafiltrable copper (CuUF) and exchangeable copper (CuEXC) was studied. Plasma was ultrafiltered in 44 presumably healthy subjects to determine CuUF and CuEXC and to set reference values ranges. The method was applied on a few patients showing good correlation between both parameters and the clinical and biological features of the patients.
引用
收藏
页码:1477 / 1484
页数:8
相关论文
共 22 条
[11]   A high resolution PIXE measurement for blood plasma ultrafiltrate [J].
KupilaRantala, T ;
Dabek, JT ;
HyvonenDabek, M .
BIOLOGICAL TRACE ELEMENT RESEARCH, 1996, 55 (1-2) :173-179
[12]  
LAU SJ, 1971, J BIOL CHEM, V246, P5938
[13]   Transcuprein is a macroglobulin regulated by copper and iron availability [J].
Liu, Nanmei ;
Lo, Louis Shi-li ;
Askary, S. Hassan ;
Jones, LaTrice ;
Kidane, Theodros Z. ;
Trang, Trisha ;
Nguyen, Minh ;
Goforth, Jeremy ;
Chu, Yu-Hsiang ;
Vivas, Esther ;
Tsai, Monta ;
Westbrook, Terence ;
Linder, Maria C. .
JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2007, 18 (09) :597-608
[14]   Determination of ceruloplasmin in human serum by SEC-ICPMS [J].
Lopez-Avila, Viorica ;
Sharpe, Orr ;
Robinson, William H. .
ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2006, 386 (01) :180-187
[15]   Direct Measurement of Free Copper in Serum or Plasma Ultrafiltrate [J].
McMillin, Gwendolyn A. ;
Travis, James J. ;
Hunt, John W. .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2009, 131 (02) :160-165
[16]  
NOUBAH AM, 1990, CLIN CHEM, V36, P860
[17]   Diagnosis and treatment of Wilson disease: An update [J].
Roberts, Eve A. ;
Schilsky, Michael L. .
HEPATOLOGY, 2008, 47 (06) :2089-2111
[18]   COMPARATIVE-STUDY OF INVITRO AND INVIVO INTERACTION OF D-PENICILLAMINE AND TRIETHYLENETETRAMINE WITH COPPER [J].
SARKAR, B ;
SASSKORTSAK, A ;
CLARKE, R ;
LAURIE, SH ;
WEI, P .
PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON, 1977, 70 :13-18
[19]   Relationship between serum copper, ceruloplasmin, and non-ceruloplasmin-bound copper in routine clinical practice [J].
Twomey, PJ ;
Vijoen, A ;
House, IM ;
Reynolds, TM ;
Wierzbicki, AS .
CLINICAL CHEMISTRY, 2005, 51 (08) :1558-1559
[20]  
WIRTH PL, 1985, JNCI-J NATL CANCER I, V75, P277